Oxytrol for Women (oxybutynin) NDC 0023-9637

NDC codes

FDA NDC Directory

Product NDC (as listed)0023-9637Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00023-9637Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0023-9637-04	00023963704	16 PATCH in 1 CARTON (0023-9637-04) / 4 d in 1 PATCHMarketed from Jan 1, 2016
0023-9637-08	00023963708	32 PATCH in 1 CARTON (0023-9637-08) / 4 d in 1 PATCHMarketed from Oct 1, 2019

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Oxytrol for Women
Generic name (nonproprietary): oxybutynin
Active ingredients: Oxybutynin — 3.9 mg/d
Dosage form: Patch
Route: Transdermal
Labeler: Allergan, Inc.
Product type: Over-the-counter drug
Marketing category: NDA — New Drug ApplicationApplication NDA 202211
Marketing start: Jan 1, 2016
Listing expires: Dec 31, 2026
Other FDA classes: Cholinergic Muscarinic Antagonists (Mechanism)
Identifiers: Product ID 0023-9637_cc404430-2345-4294-8efc-e1e996cc17b2SPL ID cc404430-2345-4294-8efc-e1e996cc17b2SPL set ID 8cdc5b4d-ff8d-4010-97d7-313422a0b868RxCUI 403799, 404448UNII K9P6MC7092
Pharmacologic class: Cholinergic Muscarinic Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Transdermal products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400023963704 followed by a unit qualifier and the quantity

Package 00023-9637-04. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 15, 2024.

Indications (excerpt from the label)

Use treats overactive bladder in women you may be suffering from overactive bladder if you have had 2 or more of the following symptoms for at least 3 months: ○ urinary frequency (the need to urinate more often than usual; typically more than 8 times in 24 hours) ○ urinary urgency (a strong need to urinate right away) ○ urge incontinence (leaking or wetting yourself if you cannot control the urge to urinate) non-drug therapies may also help you (see the consumer information leaflet inside the package)

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)